Cite
Kam YW, Lee CY, Teo TH, et al. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight. 2017;2(8)doi: 10.1172/jci.insight.92428.
Kam, Y. W., Lee, C. Y., Teo, T. H., Howland, S. W., Amrun, S. N., Lum, F. M., See, P., Kng, N. Q., Huber, R. G., Xu, M. H., Tan, H. L., Choo, A., Maurer-Stroh, S., Ginhoux, F., Fink, K., Wang, C. I., Ng, L. F., & Rénia, L. (2017). Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI insight, 2(8), . https://doi.org/10.1172/jci.insight.92428
Kam, Yiu-Wing, et al. "Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections." JCI insight vol. 2,8 (2017). doi: https://doi.org/10.1172/jci.insight.92428
Kam YW, Lee CY, Teo TH, Howland SW, Amrun SN, Lum FM, See P, Kng NQ, Huber RG, Xu MH, Tan HL, Choo A, Maurer-Stroh S, Ginhoux F, Fink K, Wang CI, Ng LF, Rénia L. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight. 2017 Apr 20;2(8). doi: 10.1172/jci.insight.92428. eCollection 2017 Apr 20. PMID: 28422757; PMCID: PMC5396524.
Copy
Download .nbib